Abstract
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release of an HPV vaccine, as well as increased availability of cancer registry data that now include reporting from a large proportion of the US population, prompted the current assessment of HPV-associated cancers. This article describes methods used to assess the burden of HPV-associated cervical, vulvar, vaginal, penile, anal, and oral cavity/oropharyngeal cancers in the United States during 1998 through 2003 using cancer registry data, and it provides a brief overview of the epidemiology of these cancers.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Alphapapillomavirus*
-
Anus Neoplasms / epidemiology
-
Anus Neoplasms / virology
-
Female
-
Genital Neoplasms, Female / epidemiology
-
Genital Neoplasms, Female / virology
-
Humans
-
Male
-
Methods
-
Neoplasms / epidemiology*
-
Neoplasms / virology*
-
Oropharyngeal Neoplasms / epidemiology
-
Oropharyngeal Neoplasms / virology
-
Papillomavirus Infections / complications*
-
Papillomavirus Infections / epidemiology
-
Penile Neoplasms / epidemiology
-
Penile Neoplasms / virology
-
Population Surveillance
-
Rectal Neoplasms / epidemiology
-
Rectal Neoplasms / virology
-
Registries*
-
SEER Program
-
United States / epidemiology